BOS-SG appears feasible and may provide physiological advantages through restoration of gastric continuity and pyloric function in selected patients with post-RYGB metabolic or nutritional complications. Larger prospective studies are needed to validate these early findings.
Huang et al. (Wed,) studied this question.